PD1.5 variant on PDCD1 gene, regulator of T lymphocyte activity, influences non-muscle-invasive bladder cancer risk (2022)
- Authors:
- Autor USP: REIS, RODOLFO BORGES DOS - FMRP
- Unidade: FMRP
- Subjects: NEOPLASIAS DA BEXIGA; NUCLEOTÍDEOS; FATORES DE RISCO; PROGNÓSTICO; LINFÓCITOS T
- Keywords: Bladder cancer; PDCD1 gene; Single-nucleotide variant; Risk; Prognosis
- Language: Inglês
- Imprenta:
- Source:
- Título: American Journal of Clinical and Experimental Urology
- ISSN: 2330-1910
- Volume/Número/Paginação/Ano: v. 10, n. 5, p. 334–340, 2022
-
ABNT
GOMEZ, Gabriela Vilas Bôas et al. PD1.5 variant on PDCD1 gene, regulator of T lymphocyte activity, influences non-muscle-invasive bladder cancer risk. American Journal of Clinical and Experimental Urology, v. 10, n. 5, p. 334–340, 2022Tradução . . Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605939/pdf/ajceu0010-0334.pdf. Acesso em: 10 mar. 2026. -
APA
Gomez, G. V. B., Longhi, L. N. A., Saito, H. P. A., Lourenço, G. J., Reis, R. B. dos, Machado, M. T., et al. (2022). PD1.5 variant on PDCD1 gene, regulator of T lymphocyte activity, influences non-muscle-invasive bladder cancer risk. American Journal of Clinical and Experimental Urology, 10( 5), 334–340. Recuperado de https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605939/pdf/ajceu0010-0334.pdf -
NLM
Gomez GVB, Longhi LNA, Saito HPA, Lourenço GJ, Reis RB dos, Machado MT, Reis LO, Denardi F, Lima CSP. PD1.5 variant on PDCD1 gene, regulator of T lymphocyte activity, influences non-muscle-invasive bladder cancer risk [Internet]. American Journal of Clinical and Experimental Urology. 2022 ; 10( 5): 334–340.[citado 2026 mar. 10 ] Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605939/pdf/ajceu0010-0334.pdf -
Vancouver
Gomez GVB, Longhi LNA, Saito HPA, Lourenço GJ, Reis RB dos, Machado MT, Reis LO, Denardi F, Lima CSP. PD1.5 variant on PDCD1 gene, regulator of T lymphocyte activity, influences non-muscle-invasive bladder cancer risk [Internet]. American Journal of Clinical and Experimental Urology. 2022 ; 10( 5): 334–340.[citado 2026 mar. 10 ] Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605939/pdf/ajceu0010-0334.pdf - Association between family history of prostate cancer and positive biopsies in a Brazilian screening program
- Effects of milk replacer feeding strategies on performance, ruminal development, and metabolism of dairy calves
- Consensus on prostate cancer treatment of localized disease with very low, low, and intermediate risk: a report from the first Prostate Cancer Consensus Conference for Developing Countries (PCCCDC)
- Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with lovalized prostate cancer: a systematic review and meta-analysis
- LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer
- Management of patients with advanced prostate cancer: the report of the advanced prostate cancer consensus conference APCCC 2017
- Urinary miRNAs as a predictor of tumor recurrence in patients with clear cell renal cell carcinoma
- Association between literacy, cancer agressiveness, and adherence in screened men for prostate cancer: results from a brazilian opportunistic screening study in 17,571 men
- Intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysis
- Modified technique for creation of an orthotopic neobladder in patients with shortened mesentery: making up the difference between the bladder and the urethral stump
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003141443.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
